LEGN
Legend Biotech Corp
NASDAQ · Healthcare · Biotechnology · US
$18.65
+0.92%Forward multiples
Based on analyst estimates
- P/E forward
- 31.93x
- P/E 2026E
- —
- P/E 2027E
- 33.64x
- P/E 2028E
- 18.07x
- P/S forward
- 2.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.95x
- Price / sales
- 2.85x
- Price / cash flow
- -19.81x
Enterprise value
- Enterprise value
- $2.9B
- EV / sales
- 2.31x
- EV / EBITDA
- 1430.34x
- EV / EBIT
- -52.37x
- Market cap
- $3.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026